
ELC Group names new senior head
pharmafile | August 22, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â Siddharth Chachad, elf groupÂ
UK regulatory affairs provider the ELC Group has confirmed the appointment of clinical pharmacologist Dr Siddharth Chachad as its head of Global Clinical Development and Medical Affairs.
Chachad has gained much experience in the delivery of medical services, medico-regulatory affairs and clinical development, and has worked across global clinical development strategy and operations of generics, new drugs and biosimilars.
A renowned speaker at numerous clinical research and pharmacovigilance conferences, Chachad has authored over 25 publications.
“The appointment of Dr Siddharth Chachad comes at a pivotal time for ELC Group,” says Marco Rubenstein, chief executive of ELC Group. “Having been instrumental in the development of successful product registration strategies, I have no doubt that Dr Siddarth will prove an exceptional leader of our Global Clinical Development and Medical Affairs team.”






